CHARLOTTES WEB HOLDINGS INC (CWEB.CA) Stock Fundamental Analysis

TSX:CWEB • CA16106R1091

0.96 CAD
+0.07 (+7.87%)
Last: Feb 11, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Overall CWEB gets a fundamental rating of 2 out of 10. We evaluated CWEB against 33 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of CWEB have multiple concerns. CWEB is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • CWEB had negative earnings in the past year.
  • In the past year CWEB has reported a negative cash flow from operations.
  • CWEB had negative earnings in each of the past 5 years.
  • In the past 5 years CWEB always reported negative operating cash flow.
CWEB.CA Yearly Net Income VS EBIT VS OCF VS FCFCWEB.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M

1.2 Ratios

  • CWEB's Return On Assets of -26.58% is on the low side compared to the rest of the industry. CWEB is outperformed by 66.67% of its industry peers.
  • Looking at the Return On Equity, with a value of -234.52%, CWEB is doing worse than 78.79% of the companies in the same industry.
Industry RankSector Rank
ROA -26.58%
ROE -234.52%
ROIC N/A
ROA(3y)-24.53%
ROA(5y)-32.75%
ROE(3y)-76.52%
ROE(5y)-69.45%
ROIC(3y)N/A
ROIC(5y)N/A
CWEB.CA Yearly ROA, ROE, ROICCWEB.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

  • The Gross Margin of CWEB (44.26%) is better than 60.61% of its industry peers.
  • CWEB's Gross Margin has declined in the last couple of years.
  • CWEB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.4%
GM growth 5Y-4.67%
CWEB.CA Yearly Profit, Operating, Gross MarginsCWEB.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • CWEB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, CWEB has more shares outstanding
  • Compared to 5 years ago, CWEB has more shares outstanding
  • CWEB has a worse debt/assets ratio than last year.
CWEB.CA Yearly Shares OutstandingCWEB.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CWEB.CA Yearly Total Debt VS Total AssetsCWEB.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • Based on the Altman-Z score of -4.39, we must say that CWEB is in the distress zone and has some risk of bankruptcy.
  • CWEB's Altman-Z score of -4.39 is on the low side compared to the rest of the industry. CWEB is outperformed by 69.70% of its industry peers.
  • CWEB has a Debt/Equity ratio of 5.28. This is a high value indicating a heavy dependency on external financing.
  • CWEB's Debt to Equity ratio of 5.28 is on the low side compared to the rest of the industry. CWEB is outperformed by 81.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.28
Debt/FCF N/A
Altman-Z -4.39
ROIC/WACCN/A
WACC8.95%
CWEB.CA Yearly LT Debt VS Equity VS FCFCWEB.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

  • CWEB has a Current Ratio of 3.89. This indicates that CWEB is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 3.89, CWEB belongs to the best of the industry, outperforming 87.88% of the companies in the same industry.
  • A Quick Ratio of 1.65 indicates that CWEB should not have too much problems paying its short term obligations.
  • CWEB's Quick ratio of 1.65 is fine compared to the rest of the industry. CWEB outperforms 72.73% of its industry peers.
Industry RankSector Rank
Current Ratio 3.89
Quick Ratio 1.65
CWEB.CA Yearly Current Assets VS Current LiabilitesCWEB.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 39.15% over the past year.
  • The Revenue has decreased by -6.83% in the past year.
  • The Revenue for CWEB have been decreasing by -12.09% on average. This is quite bad
EPS 1Y (TTM)39.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.27%
Revenue 1Y (TTM)-6.83%
Revenue growth 3Y-19.75%
Revenue growth 5Y-12.09%
Sales Q2Q%-8.61%

3.2 Future

  • The Earnings Per Share is expected to grow by 22.76% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 8.01% on average over the next years. This is quite good.
EPS Next Y35%
EPS Next 2Y28.45%
EPS Next 3Y22.76%
EPS Next 5YN/A
Revenue Next Year5.55%
Revenue Next 2Y7.32%
Revenue Next 3Y8.01%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CWEB.CA Yearly Revenue VS EstimatesCWEB.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
CWEB.CA Yearly EPS VS EstimatesCWEB.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 -0.2 -0.3

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CWEB. In the last year negative earnings were reported.
  • Also next year CWEB is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CWEB.CA Price Earnings VS Forward Price EarningsCWEB.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CWEB.CA Per share dataCWEB.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CWEB's earnings are expected to grow with 22.76% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.45%
EPS Next 3Y22.76%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for CWEB!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CHARLOTTES WEB HOLDINGS INC

TSX:CWEB (2/11/2026, 7:00:00 PM)

0.96

+0.07 (+7.87%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-12
Earnings (Next)03-17
Inst Owners1.4%
Inst Owner ChangeN/A
Ins Owners2.34%
Ins Owner ChangeN/A
Market Cap153.04M
Revenue(TTM)49.24M
Net Income(TTM)-21.69M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-12.85%
Min Revenue beat(2)-17.08%
Max Revenue beat(2)-8.61%
Revenue beat(4)0
Avg Revenue beat(4)-14.49%
Min Revenue beat(4)-26.52%
Max Revenue beat(4)-5.76%
Revenue beat(8)0
Avg Revenue beat(8)-15.8%
Revenue beat(12)0
Avg Revenue beat(12)-15.91%
Revenue beat(16)0
Avg Revenue beat(16)-16.91%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-62.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-12.51%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.18%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.29
P/FCF N/A
P/OCF N/A
P/B 12.2
P/tB 13.53
EV/EBITDA N/A
EPS(TTM)-0.19
EYN/A
EPS(NY)-0.1
Fwd EYN/A
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.12
OCFYN/A
SpS0.42
BVpS0.08
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -26.58%
ROE -234.52%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.26%
FCFM N/A
ROA(3y)-24.53%
ROA(5y)-32.75%
ROE(3y)-76.52%
ROE(5y)-69.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.4%
GM growth 5Y-4.67%
F-Score4
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 5.28
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 12.21%
Cap/Sales 1.77%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.89
Quick Ratio 1.65
Altman-Z -4.39
F-Score4
WACC8.95%
ROIC/WACCN/A
Cap/Depr(3y)21.98%
Cap/Depr(5y)104.62%
Cap/Sales(3y)4.65%
Cap/Sales(5y)9.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.27%
EPS Next Y35%
EPS Next 2Y28.45%
EPS Next 3Y22.76%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.83%
Revenue growth 3Y-19.75%
Revenue growth 5Y-12.09%
Sales Q2Q%-8.61%
Revenue Next Year5.55%
Revenue Next 2Y7.32%
Revenue Next 3Y8.01%
Revenue Next 5YN/A
EBIT growth 1Y44.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year62.55%
EBIT Next 3Y29.12%
EBIT Next 5YN/A
FCF growth 1Y19.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y9.84%
OCF growth 3YN/A
OCF growth 5YN/A

CHARLOTTES WEB HOLDINGS INC / CWEB.CA FAQ

What is the fundamental rating for CWEB stock?

ChartMill assigns a fundamental rating of 2 / 10 to CWEB.CA.


Can you provide the valuation status for CHARLOTTES WEB HOLDINGS INC?

ChartMill assigns a valuation rating of 1 / 10 to CHARLOTTES WEB HOLDINGS INC (CWEB.CA). This can be considered as Overvalued.


Can you provide the profitability details for CHARLOTTES WEB HOLDINGS INC?

CHARLOTTES WEB HOLDINGS INC (CWEB.CA) has a profitability rating of 1 / 10.


How financially healthy is CHARLOTTES WEB HOLDINGS INC?

The financial health rating of CHARLOTTES WEB HOLDINGS INC (CWEB.CA) is 3 / 10.